Colour enhancement

From PsychonautWiki
(Redirected from Color enhancement)
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
THJ-2201
Methallylescaline
Experience:4-HO-MiPT / A care free psychedelic getaway
3-MMC
Aniracetam
PARGY-LAD
Cannabis
TMA-2
MiPT
25C-NBOH
Bufotenin
Experience:1mg 25c-NBOMe - Experiment in my room
4-AcO-DiPT
Proscaline
3-MeO-PCE
Efavirenz
2C-E
Enhancement of colour rose.jpgRose by Chelsea Morgan
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
THJ-018
4-HO-DPT
TMA-6
Omberacetam
DOM
DMT
5-MeO-DiPT
Memantine
2C-H
MiPLA
DiPT
5-MeO-MiPT
Experience:25mg 3-MeO-PCP - Enhanced film experience
25B-NBOH
Experience:337mg DMT fumarate - A Day With DMT
AL-LAD
Pramiracetam
DPT
MDEA
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
MDA
Experience:300µg AL-LAD - Don't worry, because you're everyone!
EPT
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
4-AcO-DMT
Bromo-DragonFLY
Experience:300µg LSD - Togetherness and the Silent Dusk
25D-NBOMe
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
ΑMT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Tree.jpgJapanese Garden by Anonymous
DOI
Experience:40mg - Brothermind and the Forest's Hand
Selective serotonin reuptake inhibitor
2C-I
Experience:120mg - Garden of The Gods
Chur City in Switzerland.jpgChur, Switzerland by Naps284
JWH-073
Ibogaine
ETH-LAD
2C-B-FLY
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
5-MeO-DiBF
1P-LSD
Psilocin
4-AcO-DET
MET
ALD-52
Phenethylamine (compound)
2C-C
GABAergic hallucinogens
DOB
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
2C-D
3C-E
Phenylpiracetam
2C-B
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
DET
Experience:2 tabs DOB - My DOB Nightmare
1B-LSD
Experience:250mg DXM - DXM Itch and Trip Report
4-HO-DET
MDAI
Ayahuasca
25B-NBOMe
Experience:4-AcO-DMT + 200mg Pill
5F-PB-22
Experience:1000 Morning Glory seeds - Rediscovering the Self
6-APDB
4-HO-MET
Experience:4.5g - The Grand Introduction to Beauty and Fear
25I-NBOMe
Allylescaline
LSZ
LSD
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
4-AcO-MiPT
2C-T-2
25C-NBOMe
25N-NBOMe
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
MPT
5-Hydroxytryptophan
Pregabalin
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
MDMA
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
4-HO-MPT
Psilocybin mushrooms
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Experience:3g mimosa / 3g syrian rue - Connecting with my body
4-AcO-MET
Experience:1050 µg 1cP-LSD - The matrix
Chameleon.jpgChameleon by Anonymous.
Mescaline
5-MeO-DALT
Oxiracetam
LSM-775
4-HO-MiPT
JWH-018
Experience:4x 200ug tabs - You do not need to understand
Experience:25mg Deschloroketamine - My first time orally dosing DCK
PRO-LAD
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
4-HO-DiPT
6-APB
Experience:3-MeO-PCP - Extreme psychosis
Amanita muscaria
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
1P-ETH-LAD
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
4-FA
Escaline
25I-NBOH
Coluracetam
Experience:800 seeds LSA - My First Trip Ever
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
LSA
Βk-2C-B
2C-T-21
Piracetam
2C-T-7
Experience:BK-2C-B - Various experiences
Paradise island by Xanny.jpgParadise island by Subsentience
DOC
Experience:~150mg MDA(oral) - a case of mistaken identity
4-HO-EPT
2C-P

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.